This suggests that CSP‐TTK21, by activating the master epigenetic enzyme p300/CBP, could rescue some of the de‐regulated processes (such as synaptic plasticity and neurodegeneration) associated with AD. The gene discussed is EP300; the disease is Alzheimer disease.